Trial Profile
A prospective, multicenter, open-label study to evaluate the safety and efficacy of the 28-day oral contraceptive DR-1021
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2007
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/desogestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Duramed Pharmaceuticals Inc
- 11 Dec 2006 Status change
- 17 Nov 2006 New trial record.